Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Deliveliotis

Showing results (81-90 of 81) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 81 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)A Bamias, U Dafni, A Karadimou, et al.
Pageof 9

Showing results (81-90 of 81) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 81 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)A Bamias, U Dafni, A Karadimou, et al.
Pageof 9